Respiratory Flashcards
Describe the pathophysiology of asthma
Reversible increased resistance to airflow due to airway narrowing during attack. Patients have normal physiology between the attacks. Caused by bronchospasm or inflammation.
Airway narrowing in asthma is caused by?
- bronchospasm
- inflammation
What are the triggering factors for Asthma
- Airway irritants
- Exercise, cold air, dry air
- Resp infection; upper/lower
- ASA from overproduction of leukotriens
- Beta blockers
- GERD
Identify the clinical features of asthma
- SOB Cough,
- chest tightness
- Wheezing
- Dyspnea
- Worst at night
What are the physical exam findings of Asthma between attacks
- Normal physical examination
- Abnormal PFT
What are the physical exam findings of Asthma during attacks
- Tachypnea
- Inspiratory and expiratory wheezing
- Use of accessory muscles
- pulsus paradoxus
- Paradoxical movement of abdomen
Identify the diagnosis criteria for asthma
Decreased Peak flow expiratory rate
FVC, FEV1 and FEV1/FVC decreases
- Increased RV
- Normal diffusion capacity
- Improvement of flow rate with bronchodilators
- Bronchial hyperesponsiveness to histamine
- Eosinophilia
- CXR: hypeinflation; flatening of diaphragm; mucus plug; atelectasis
- ABG: Hypocapnia; Mild hypoxemia; Hypocarbia is common
What are CXR diagnostic findings for asthma
- Hypeinflation
- Flatening of diaphragm
- Mucus plug .
- Atelectasis
What are the ABG diagnostic findings for asthma
Hypocapnia
Mild hypoxemia
Hypocarbia is common
Tachypnea in presence of normal or high CO2 (40@40) = Respiratory Emergency, respiratory failure will occur. Intubation is indicated.
Describe the treatment of asthma
Anti-inflamatory drugs
Bronchodilators
Anti-leukotrienes- Zileuton(Zyflo)
Montelukast (Singulair) and Zafirlukast
Anti-IgE monoclonal therapy
Describe the use of Anti-inflamatory drugs for treatment of Asthma
- Inhaled Steroids
- Systemic Steroids
- Cromolyn to prevent mast cell degranulation
This drug is used only for prophylaxis and not acute asthma attacks. It can also be used to prevent exercise induced asthma
Cromolyn
Describe the use of bronchodilators for treatment of Asthma
- Beta 2 agonists
- Anticholinergics
- Aminophyline preparations
- theophyline: PDE inhibitor with narrow therapeutic index
This drug is a PDE inhibitor with a narrow therapeutic index, used as a bronchodilator
theophyline
Describe the use of Anti-leukotrienes- Zileuton(Zyflo) for treatment of Asthma
- 5-lipoxigenase inhibitor
- Blocks conversion of arachidonic acid to leukotriene
- Adverse effects; Dyspnea, arthralgia, chest pain, fever
This drug can cause Dyspnea, arthralgia, chest pain, and fever
Anti-leukotrienes- Zileuton(Zyflo)
Describe the use of Montelukast (Singulair) and Zafirlukast for treatment of Asthma
- Competitive antagonist of leukotriene on cysteinyl-leukotriene1 receptor.
- Prevent bronchospasm, vasoconstriction and eosinophil recruitment.
- Good for aspirin induced asthma
Blocks the conversion of arachidonic acid to leukotriene
Zileuton (zyflo): 5-lipoxygenase inhibitor
Competitive antagonist of leukotriene on cysteinyl-leukotriene1 receptor
Montelukast (singulair) and Zafirlukast
Describe the use of Anti-IgE monoclonal therapy for treatment of Asthma
Use Omalizumab which binds free IgE
This drug binds free IgE
Omalizumab
Describe the management of acute asthma attack
- Beta agonist + steroid + ipatropium
- Systemic steroids IV
- Aminophyline not effective in severe acute attack
Describe the management of chronic asthma
Inhaled steroids as maintenance + beta 2 agonist for symptomatic control
Add ipatropium
Consider aminophyline
Short course steroids
3 messenger systems for bronchial smooth muscle tone are?
Beta 2 stimulant via Gs Protein
Nitric oxide via cGMP
Cholinergic muscarinic via IP3
Destruction of alveolar walls and abnormal enlargement of air spaces distal to terminal bronchiole
Chronic pulmonary emphysema
Chronic pulmonary emphysema is defined as?
Destruction of alveolar walls and abnormal enlargement of air spaces distal to terminal bronchiole
Most common cause of Chronic pulmonary emphysema is?
Smoking
Features of Chronic pulmonary emphysema
Chronic infection
Chronic obstruction
Co2 retention due to decreased diffusion capacity
Hypoxia and hypercapnia due to V/Q mismatch
Cor pulmonale due to pulmonary hypertension
What is the pathogenesis of emphysema
Inflamatory cells are recruited to the lungs due to long term exposure to smoking.
They release proteinases in excess of inhibitors
If repair is abnormal, airspace destruction and enlargement results (Emphysema).
Features of COPD
Fourth leading cause of death in US
Emphysema
Chronic bronchitis
Both characterized by chronic airway obstruction, dyspnea, caugh, sputum production
MCC is smoking -> PMNs (polumorphonucleus cells) and macrophages -> increased free radicals
Other causes apha1 antitrypsin deficiency- antiprotease, second hand smoking, chronic asthma
This drug has no receptor, it crosses the cell membrane and its action results in bronchodilation
Nitric oxide via cGMP
Patient has a teardrop shaped heart on CXR. What is his most likely diagnosis
COPD
This is the 4th leading cause of death in USA
COPD
Airway inflammation lasting >2years
Chronic bronchitis
Pathophysiology of smoking in the lungs
increases PMNs (polumorphonucleus cells) and macrophages leading to increased free radicals
In COPD diagnosis FE, FEV1 and FEV1/FVC ratio is increased or decreased?
FEV1 and FEV1/FVC ratio is decreased
Prolonged FE>6 seconds
In COPD diagnosis CXR findings would show?
Hyperinflated lungs
Bullae
Flattening diaphragm
Decreased vascular markings
Decreased lung markings
In COPD diagnosis ABG findings would show?
Compensated respiratory acidosis
CO2 retention that worsens with supplemental oxygen
Residual volume and Total lung capacity in COPD
Residual volume and Total lung capacity are increased due to air trapping
Diagnostic signs and symptoms of COPD are?
Chronic dyspnea cough
Wheezing
sputum production
airflow obstruction of PFTs
Diminished breathing sounds, wheezing
JVD, peripheral edema and hepatomegaly due to Cor pulmonale
DLCO in COPD is increased/decreased?
decreased due to emphysema
Hematologic finding in COPD
Polycythemia
Treatment of COPD
Smoking cessation
ABX for H.influenzae, S.pneumoniae
Bronchodilators
Steroid- demonstrate effectiveness with PFT
Supplemental O2 with PO2<55 -improves survival
Complications of COPD
Acute exacerbation after infection
Polycythemia
Pulmonary HTN
Cor pulmonale
Anesthetic considerations for COPD
VA anesthetics are potent bronchodilators except for des
Protect against reflex bronchoconstriction during intubation/suction in COPD and Asthma
Propofol agent of choice
This drug can cause pulmonary fibrosis
Bleomycin
Pulmonary fibrosis pathophysiology
Is a restrictive disease with decreased lung compliance in which inspiration is impaired due to scarring of lungs with increased collagen
Decreased lung volumes
Increased or normal FEV1/FVC ratio because FEV1 is only slightly low whereas FVCis significantly low
This drug can cause Rales,cough, infiltration and fetal fibrosis
Bleomycin
Patient has significantly low FEV1 and FV1/FVC and slightly low FVC with High FRC. What is the possible diagnosis
COPD or Asthma (Obstructive condition)
Patient has a normal to slightly increased FV1/FVC ratio slightly low FEV1, significantly decrease FVC and low FRC. What is the possible diagnosis
Fibrosis (Restrictive condition)